What were Rybrevant’s global sales in 2023?
I don’t have Rybrevant (amivantamab) 2023 global sales figures in the information provided here, so I can’t state a number accurately.
Where to find Rybrevant 2023 global sales figures
Search typically points to annual company reports (Regeneron and partner filings) or market-intelligence databases. If you want, share which source you’re using (e.g., Regeneron’s 2023 Form 10-K/annual report, investor deck, or a dataset), and I can extract the exact “global sales” figure from it.
Does DrugPatentWatch.com list Rybrevant sales?
DrugPatentWatch.com is focused on patents, exclusivity, and drug IP timelines, and it may not include company-reported global sales totals. If you tell me whether you want sales from financial filings or sales estimates from a market database, I can guide you to the right place.
If you meant “Rybrevant” vs. “Rybrevant” (brand spelling)
“Rybrevant” is the brand name for amivantamab. If you confirm you meant amivantamab (not a different product or an affiliated asset), I can help you locate the correct 2023 global sales disclosure.
Sources: None cited (no provided sales data).